Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App




Highly Sensitive Detection Method Monitors HDL Kinetics

By LabMedica International staff writers
Posted on 28 Apr 2016
Print article
Image: The Q Exactive hybrid quadrupole orbitrap mass spectrometer (Photo courtesy of Thermo Fisher Scientific).
Image: The Q Exactive hybrid quadrupole orbitrap mass spectrometer (Photo courtesy of Thermo Fisher Scientific).
High-density lipoprotein (HDL) is often referred to as good cholesterol, and high levels of HDL are associated with lower risk of cardiovascular disease, but many clinical outcome trials for drugs that raise HDL levels have failed to show significant benefits for trial participants.

Current HDL detection methods usually measure only total HDL cholesterol, but a more sensitive detection method could allow investigators to measure the subfractions of HDL, and more precisely pinpoint which of these subfractions should be raised to help protect against cardiovascular events.

Scientists at Brigham and Women's Hospital (Boston, MA, USA) and their colleagues studied three participants, two female and one male who were ages 25, 33, and 49 years old; were overweight or obese with a body mass index (BMI) of 26, 31, and 31 kg/m2; and had low HDL-C levels of 48, 37, and 24 mg/dl, respectively. The three participants ate a controlled, high-unsaturated-fat diet for 32 days, 28 days prior to the kinetic study, and four days during the kinetic study.

Total plasma leucine (D3-Leu labeled and endogenous) was isolated from 0.2 mL of plasma from different time points and measured using a Gas Chromatograph/ Mass Spectrometer (GC/MS) 6890 GC, 5973 MS, (Agilent Technologies, Santa Clara, CA, USA). HDL was separated by size using nondenaturing polyacrylamide gel electrophoresis (ND-PAGE). Spectral counting was used for the relative quantification of the apolipoproteins. Peptide samples were analyzed with the Q Exactive mass spectrometer fronted with a Nanospray FLEX ion source, and coupled to an Easy-nLC1000 High performance liquid chromatography (HPLC) pump (Thermo Fisher Scientific, Bremen, Germany).

The investigators were able to identify 58 proteins in HDL that were shared among three participants. They followed up on seven of these proteins, monitoring their kinetics to better understand apolipoprotein metabolism and the formation of HDL particles. Their results suggest that the traditional view of the role of HDL in reverse cholesterol transport may oversimplify the roles and contributions of various components of HDL.

The authors concluded that their study demonstrated the feasibility of closer monitoring of HDL kinetics. They believe that establishing new, high-resolution methods that can monitor HDL kinetics is critical to examine the desired effects of new drugs. This approach not only revealed novel evidence for the formation of HDL particles, but also found that each HDL subfraction has a unique proteome, which may help to discover new therapeutic targets. The study was published on April 1, 2016, in Journal of Lipid Research.

Related Links:
Brigham and Women's Hospital
Agilent Technologies
Thermo Fisher Scientific
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
New
Respiratory QC Panel
Assayed Respiratory Control Panel

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.